NGEN
NervGen Pharma Corp. Common stock
NASDAQ · Healthcare · Biotechnology · CA
$2.33
+0.43%Margins
Gross margin
—
EBITDA margin
—
EBIT margin
—
Net margin
—
FCF margin
—
-390.4%
Return on equity
-74.8%
Return on assets
-219.9%
Return on invested capital
0.00x
Asset turnover
-$21.5M
Cash from operations
$0.59
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026